206 related articles for article (PubMed ID: 23836117)
1. Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin.
Nordeen SK; Bona BJ; Jones DN; Lambert JR; Jackson TA
Horm Cancer; 2013 Oct; 4(5):293-300. PubMed ID: 23836117
[TBL] [Abstract][Full Text] [Related]
2. An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders.
Taliou A; Zintzaras E; Lykouras L; Francis K
Clin Ther; 2013 May; 35(5):592-602. PubMed ID: 23688534
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of luteolin cytotoxicity by flavonols fisetin and quercetin in human chronic lymphocytic leukemia cell lines.
Sak K; Kasemaa K; Everaus H
Food Funct; 2016 Sep; 7(9):3815-24. PubMed ID: 27489195
[TBL] [Abstract][Full Text] [Related]
4. Dietary flavonoids, luteolin and quercetin, inhibit invasion of cervical cancer by reduction of UBE2S through epithelial-mesenchymal transition signaling.
Lin TH; Hsu WH; Tsai PH; Huang YT; Lin CW; Chen KC; Tsai IH; Kandaswami CC; Huang CJ; Chang GD; Lee MT; Cheng CH
Food Funct; 2017 Apr; 8(4):1558-1568. PubMed ID: 28277581
[TBL] [Abstract][Full Text] [Related]
5. Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells.
Tsai PH; Cheng CH; Lin CY; Huang YT; Lee LT; Kandaswami CC; Lin YC; Lee KP; Hung CC; Hwang JJ; Ke FC; Chang GD; Lee MT
Anticancer Res; 2016 Dec; 36(12):6367-6380. PubMed ID: 27919958
[TBL] [Abstract][Full Text] [Related]
6. Effects of dietary flavonoids, luteolin, and quercetin on the reversal of epithelial-mesenchymal transition in A431 epidermal cancer cells.
Lin YS; Tsai PH; Kandaswami CC; Cheng CH; Ke FC; Lee PP; Hwang JJ; Lee MT
Cancer Sci; 2011 Oct; 102(10):1829-39. PubMed ID: 21752154
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin.
Cantero G; Campanella C; Mateos S; Cortés F
Mutagenesis; 2006 Sep; 21(5):321-5. PubMed ID: 16950806
[TBL] [Abstract][Full Text] [Related]
8. Distribution and biological activities of the flavonoid luteolin.
López-Lázaro M
Mini Rev Med Chem; 2009 Jan; 9(1):31-59. PubMed ID: 19149659
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative Activity and Mechanisms of Action of Plant-derived Flavonoids on Breast Cancer.
Criollo-Mendoza MS; Heredia JB; Vazquez-Olivo G; Avilés-Gaxiola S; Gutiérrez-Grijalva EP; Garcia-Carrasco M
Curr Top Med Chem; 2023; 23(20):1937-1951. PubMed ID: 37183471
[TBL] [Abstract][Full Text] [Related]
10. Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals.
Cai Q; Rahn RO; Zhang R
Cancer Lett; 1997 Oct; 119(1):99-107. PubMed ID: 18372528
[TBL] [Abstract][Full Text] [Related]
11. Antitumor Effect and Gut Microbiota Modulation by Quercetin, Luteolin, and Xanthohumol in a Rat Model for Colorectal Cancer Prevention.
Pérez-Valero Á; Magadán-Corpas P; Ye S; Serna-Diestro J; Sordon S; Huszcza E; Popłoński J; Villar CJ; Lombó F
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674851
[TBL] [Abstract][Full Text] [Related]
12. Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity.
Johnson JL; Rupasinghe SG; Stefani F; Schuler MA; Gonzalez de Mejia E
J Med Food; 2011 Apr; 14(4):325-33. PubMed ID: 21443429
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hydroxycinnamic acid sulfation by flavonoids and their conjugated metabolites.
Wong CC; Williamson G
Biofactors; 2013; 39(6):644-51. PubMed ID: 24038617
[TBL] [Abstract][Full Text] [Related]
14. Combination treatment with luteolin and quercetin enhances antiproliferative effects in nicotine-treated MDA-MB-231 cells by down-regulating nicotinic acetylcholine receptors.
Shih YL; Liu HC; Chen CS; Hsu CH; Pan MH; Chang HW; Chang CH; Chen FC; Ho CT; Yang YY; Ho YS
J Agric Food Chem; 2010 Jan; 58(1):235-41. PubMed ID: 19921817
[TBL] [Abstract][Full Text] [Related]
15. Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis.
Mittra B; Saha A; Chowdhury AR; Pal C; Mandal S; Mukhopadhyay S; Bandyopadhyay S; Majumder HK
Mol Med; 2000 Jun; 6(6):527-41. PubMed ID: 10972088
[TBL] [Abstract][Full Text] [Related]
16. Brain inflammation, neuropsychiatric disorders, and immunoendocrine effects of luteolin.
Theoharides TC; Conti P; Economu M
J Clin Psychopharmacol; 2014 Apr; 34(2):187-9. PubMed ID: 24525647
[No Abstract] [Full Text] [Related]
17. Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases.
Boersma MG; van der Woude H; Bogaards J; Boeren S; Vervoort J; Cnubben NH; van Iersel ML; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2002 May; 15(5):662-70. PubMed ID: 12018987
[TBL] [Abstract][Full Text] [Related]
18. Anti-carcinogenic effects of the flavonoid luteolin.
Seelinger G; Merfort I; Wölfle U; Schempp CM
Molecules; 2008 Oct; 13(10):2628-2651. PubMed ID: 18946424
[TBL] [Abstract][Full Text] [Related]
19. Flavonoids protect against cytokine-induced pancreatic beta-cell damage through suppression of nuclear factor kappaB activation.
Kim EK; Kwon KB; Song MY; Han MJ; Lee JH; Lee YR; Lee JH; Ryu DG; Park BH; Park JW
Pancreas; 2007 Nov; 35(4):e1-9. PubMed ID: 18090225
[TBL] [Abstract][Full Text] [Related]
20. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor.
Huang YT; Hwang JJ; Lee PP; Ke FC; Huang JH; Huang CJ; Kandaswami C; Middleton E; Lee MT
Br J Pharmacol; 1999 Nov; 128(5):999-1010. PubMed ID: 10556937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
